HIGHLIGHTS
- who: October and colleagues from the Alam, Malaysia Lund University, Sweden have published the article: Ef cacy and safety of tirzepatide in patients with type 2 diabetes: A systematic review and meta-analysis, in the Journal: (JOURNAL) of 25/03/2022
- what: Sensitivity analysis was conducted to assess the stability of the pooled effects.
SUMMARY
There are two systematic reviews and meta-analyses on the evaluation of the effectiveness of tirzepatide on the treatment of diabetes (Bhagavathula et_al, 2021; Dutta et_al, 2021). The trials lasted from 26 to 52 weeks and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.